Abstract
Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor contributing to opiate abuse1,2. Increased noradrenaline in the brain has long been implicated in opiate withdrawal3, but it has not been clear which noradrenergic systems are involved. Here we show that microinjection of β-noradrenergic-receptor antagonists, or of an α2-receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly attenuates opiate-withdrawal-induced conditioned place aversion. Immunohistochemical studies revealed that numerous BNST-projecting cells in the A1 and A2 noradrenergic cell groups of the caudal medulla were activated during withdrawal. Lesion of these ascending medullary projections also greatly reduced opiate-withdrawal-induced place aversion, whereas lesion of locus coeruleus noradrenergic projections had no effect on opiate-withdrawal behaviour. We conclude that noradrenergic inputs to the BNST from the caudal medulla are critically involved in the aversiveness of opiate withdrawal.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bechara, A., Nader, K. & van der Kooy, D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol. Biochem. Behav. 59, 1–17 (1998).
O'Brien, C. P., Childress, A. R., McLellan, A., Ehrman, R. & Ternes, J. Types of conditioning found in drug-dependent humans. NIDA Res. Monogr. 84, 44– 61 (1988).
Maldonado, R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21, 91–104 ( 1997).
Aston-Jones, G., Shiekhattar, R., Rajkowski, J., Kubiak, P. & Akaoka, H. in The Neurobiology of Opiates (ed. Hammer, R.) 175–202 (CRC Press, Boca Raton, Florida, 1993).
Alheid, G. F., de Olmos, J. S. & Beltramino, C. A. in The Rat Nervous System 2nd edn (ed. Paxinos, G.) 495–578 (Academic, San Diego, 1995).
Brownstein, M. J. & Palkovits, M. in Handbook of Chemical Neuroanatomy, Vol. 2. Classical Transmitters in the CNS, Part 1 (eds Bjorklund, A. & Hokfelt, T.) 23–54 (Elsevier, Amsterdam, 1984).
Terenzi, M. G. & Ingram, C. D. A combined immunocytochemical and retrograde tracing study of noradrenergic connections between the caudal medulla and the bed nuclei of the stria terminalis. Brain Res. 672, 289–297 (1995).
Akaoka, H., Zhu, Y., Shipley, M. T. & Aston-Jones, G. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18, 374 (1992).
Stornetta, R. L., Norton, F. E. & Guyenet, P. G. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 624, 19–28 (1993).
Harris, G. & Aston-Jones, G. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology 9, 303–311 ( 1993).
Fritschy, J. M., Geffard, M. & Grzanna, R. The response of noradrenergic axons to systematically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-β-hydroxylase. J. Chem. Neuroanat. 3, 309–321 ( 1990).
Christie, M. J., Williams, J. T., Osbourne, P. B. & Bellchambers, C. E. Where is the locus of opioid withdrawal? Trends Pharmacol. Sci. 18, 134–140 ( 1997).
Caille, S. et al. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J. Pharmacol. Exp. Ther. 290, 881– 892 (1999).
Nader, K. & van der Kooy, D. Clonidine antagonizes the aversive effects of opiate withdrawal and the rewarding effects of morphine only in opiate withdrawn rats. Behav. Neurosci. 110, 389–400 (1996).
Gold, M. S., Redmond, D. E. & Kleber, H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet (ii), 599–602 (1978).
Roehrich, H. & Gold, M. S. Propranolol as adjunct to clonidine in opiate detoxification. Am. J. Psychiat. 144, 1099–1100 (1987).
Grosz, H. J. Narcotic withdrawal symptoms in heroin users treated with propranolol. Lancet (ii), 564–566 ( 1972).
Chieng, B. & Christie, M. J. Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci. Lett. 186, 37– 40 (1995).
Britton, K. T., Svensson, T., Schwartz, J., Bloom, F. E. & Koob, G. F. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 34, 133–139 ( 1984).
Blessing, W. W. The Lower Brainstem and Bodily Homeostasis (Oxford Univ. Press, New York, 1997).
Stinus, L., Le Moal, M. & Koob, G. F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37, 767–773 ( 1990).
Schulteis, G., Markou, A., Gold, L. H., Stinus, L. & Koob, G. F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271, 1391–1398 (1994).
Higgins, G. A. & Sellers, E. M. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharm. Biochem. Behav. 48, 1– 8 (1994).
Pothos, E., Rada, P., Mark, G. P. & Hoebel, B. G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566, 348–350 (1991).
McKittrick, C. R., Delfs, J. M., Aston-Jones, G. & Abercrombie, E. D. Differential spontaneous and withdrawal-induced efflux of catecholamines in nucleus accumbens shell of morphine-treated rats. Soc. Neurosci. Abstr. 25, 948 (1999).
Harris, G. & Aston-Jones, G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371, 155–157 ( 1994).
Drolet, G., Van Bockstaele, E. J. & Aston-Jones, G. Robust enkephalin innervation of the locus coeruleus from the rostral medulla. J. Neurosci. 12 , 3162–3174 (1992).
Chen, S. & Aston-Jones, G. Extensive projections from the midbrain periaqueductal gray to the caudal ventrolateral medulla: A retrograde and anterograde tracing study in the rat. Neurosci. 71, 443–459 (1996).
Everitt, B. J., Robbins, T. W., Gaskin, M. & Fray, P. J. The effects of lesions to ascending noradrenergic neurons on discrimination learning and performance in the rat. Neuroscience 10, 397–410 (1983).
Tejani-Butt, S. M. 3H-nisoxetine: a radioligand for quantification of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharm. Exp. Ther. 260, 427–436 ( 1992).
Acknowledgements
We thank C. Walters and K. Altomare for technical assistance; G. Stanwood for assistance with autoradiography; and S. Aston-Jones for assistance with figures. This work was supported by the National Institute of Drug Abuse, NIH. ST-91 was generously donated by Boehringer-Ingelheim.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delfs, J., Zhu, Y., Druhan, J. et al. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403, 430–434 (2000). https://doi.org/10.1038/35000212
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35000212
This article is cited by
-
Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies
Molecular Psychiatry (2023)
-
Opioid withdrawal: role in addiction and neural mechanisms
Psychopharmacology (2023)
-
Manual segmentation of the paraventricular nucleus of the hypothalamus and the dorsal and ventral bed nucleus of stria terminalis using multimodal 7 Tesla structural MRI: probabilistic atlases for a stress-control triad
Brain Structure and Function (2023)
-
Neurocircuitry of Mindfulness-Based Interventions for Substance Use Prevention and Recovery
Current Addiction Reports (2021)
-
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
Neuropsychopharmacology (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.